PhysiciansNCT06836466
Physicians' Awareness of ECG Abnormalities Linked to Acute Ischemic Chest Pain
An observational study of Physicians and Awareness, run by Tanta University at 1 site in Egypt.
Trial summary
This study aims to investigate physicians' awareness regarding patients presenting with potential acute ischemic chest pain. It focuses on various electrocardiogram (ECG) patterns requiring prompt catheter lab activation for reperfusion therapy alongside other ECG mimics that may lead to false catheter lab activations. Read more about this study
- Who is it for?
- Ages 25 to 65 years
- Conditions the study is for
- Physicians, Awareness, ECG Abnormalities
- What is being tested?
- Google Form-based questionnaire
- How many people
- 640 participants
- Where
- 1 siteEgypt
- Study dates
- 20 Feb 2025to 30 Sep 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: A consecutive sample of 500 physicians who treat patients with possible acute ischemic chest pain will be the subject of this cross-sectional survey study. These doctors will include emergency physicians, cardiologists, internal medicine/acute medicine specialists, general practice or family physicians, anesthesiologists, and intensive care physicians of both sexes, with varying degrees of experience and post-graduate clinical training, from all over the world.
Who may be able to join
- Age from 25 to 65 years.
- Both sexes.
- Physicians who treat patients with possible acute chest pain.
Who cannot join
- Participants who failed to complete the survey questions.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Physicians' Awareness of ECG Abnormalities Linked to Acute Ischemic Chest Pain; A Survey Study
This study aims to investigate physicians' awareness regarding patients presenting with potential acute ischemic chest pain. It focuses on various electrocardiogram (ECG) patterns requiring prompt catheter lab activation for reperfusion therapy alongside other ECG mimics that may lead to false catheter lab activations.
Read the detailed description
Chest pain is the second most common complaint in adult emergency department (ED) patients in the United States. Most visits result in a diagnosis of noncardiac chest pain and approximately half in nonspecific chest pain. Roughly 6% are ultimately diagnosed with a life-threatening condition, which is overwhelmingly (>90%) acute coronary syndrome (ACS).
The term acute coronary syndrome (ACS) is applied to patients in whom there is a suspicion or confirmation of acute myocardial ischemia or infarction. ST-elevation myocardial infarction (STEMI), Non-ST-elevation MI (NSTEMI), and unstable angina are the three traditional types of ACS.
- Conditions
- Physicians, Awareness, ECG Abnormalities, Acute Ischemic Chest Pain
- Being tested
- Google Form-based questionnaire
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Google Form-based questionnaireOther
All participants will consent to submit an anonymous Google Form-based questionnaire. The designed questionnaire includes introductory personal, academic, and work experience data about the physicians as gender, age, current specialty, workplace, highest achieved medical-academic or training degree, and number of years of postgraduate clinical work experience.
| Study group | Role | What they receive |
|---|---|---|
| Group 1 | All physicians are subjected to 10 ECGs Surves Receives: Other: Google Form-based questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Physicians' Awareness
Physicians' awareness is measured by a numerical score of 0 to 10, depending on the electrocardiogram (ECG) pattern survey. 0 means (least recognition of ECG pattern) and 10 (high recognition of ECG pattern)
Measured: At time of online survey (Up to 2 months)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Feb 2025
- Study start20 Feb 2025
- Primary completion29 Aug 2025
- Study completion30 Sep 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PhysiciansStudies of the same condition, open and under way.
- More trials run by Tanta UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 640 participants (actual)
Sponsor and investigators
- Lead sponsor
- Tanta University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Ezzat Nasreddin, Tanta University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06836466
- Sponsor's protocol ID
- 36264PR955/11/24
- Status last verified
- Feb 2025
- First submitted
- 13 Feb 2025
- Last updated
- 18 Nov 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Study at a glance
From the registry record, last updated by the sponsor on 18 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Physicians' Awareness of ECG Abnormalities Linked to Acute Ischemic Chest Pain; A Survey Study
- ClinicalTrials.gov ID
- NCT06836466
- Acronym / sponsor ID
- 36264PR955/11/24
- Conditions
- Physicians, Awareness, ECG Abnormalities, Acute Ischemic Chest Pain
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 640 participants (actual)
- Lead sponsor
- Tanta UniversityUniversity, hospital or other
- Study start
- 20 Feb 2025 (actual)
- Primary completion
- 29 Aug 2025 (actual)
- Study completion
- 30 Sep 2025 (actual)
- First posted
- 20 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to investigate physicians' awareness regarding patients presenting with potential acute ischemic chest pain. It focuses on various electrocardiogram (ECG) patterns requiring prompt catheter lab activation for reperfusion therapy alongside other ECG mimics that may lead to false catheter lab activations.
Detailed description
Chest pain is the second most common complaint in adult emergency department (ED) patients in the United States. Most visits result in a diagnosis of noncardiac chest pain and approximately half in nonspecific chest pain. Roughly 6% are ultimately diagnosed with a life-threatening condition, which is overwhelmingly (>90%) acute coronary syndrome (ACS).
The term acute coronary syndrome (ACS) is applied to patients in whom there is a suspicion or confirmation of acute myocardial ischemia or infarction. ST-elevation myocardial infarction (STEMI), Non-ST-elevation MI (NSTEMI), and unstable angina are the three traditional types of ACS.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Group 1 | – | Other: Google Form-based questionnaireAll physicians are subjected to 10 ECGs Surves |
Who may qualify
- Ages
- 25 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- A consecutive sample of 500 physicians who treat patients with possible acute ischemic chest pain will be the subject of this cross-sectional survey study. These doctors will include emergency physicians, cardiologists, internal medicine/acute medicine specialists, general practice or family physicians, anesthesiologists, and intensive care physicians of both sexes, with varying degrees of experience and post-graduate clinical training, from all over the world.
Key inclusion criteria (3 listed)
- Age from 25 to 65 years.
- Both sexes.
- Physicians who treat patients with possible acute chest pain.
Key exclusion criteria (1 listed)
- Participants who failed to complete the survey questions.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Google Form-based questionnaireAll participants will consent to submit an anonymous Google Form-based questionnaire. The designed questionnaire includes introductory personal, academic, and work experience data about the physicians as gender, age, current specialty, workplace, highest achieved medical-academic or training degree, and number of years of postgraduate clinical work experience. | Other | Group 1 |
Primary outcome
Physicians' Awareness
Time frame: At time of online survey (Up to 2 months)
Physicians' awareness is measured by a numerical score of 0 to 10, depending on the electrocardiogram (ECG) pattern survey. 0 means (least recognition of ECG pattern) and 10 (high recognition of ECG pattern)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Nov 2025.
- Individual participant dataSharing planned: Yes. The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Related trials for Physicians
Recruiting
AI-Assisted Interpretation of Cardiac CT in the Emergency Department
Chest Pain, Acute Coronary Syndrome
Recruiting
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
Physician's Role, Smoking Cessation
Recruiting
Physician Engagement in EMS Transport Refusal Rates
Refusal of Transport
RecruitingObservational study
A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions
Pancreatic Cystic Lesions
Enrolling by invitation
Topical Ruxolitinib Versus Tacrolimus With Excimer Laser for Localized Vitiligo
Vitiligo, Nonsegmental Vitiligo
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Physicians and Awareness, run by Tanta University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Physicians' Awareness (time frame: At time of online survey (Up to 2 months)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2025.